Ortho-quinones of benzene and estrogens induce hyperproliferation of human peripheral blood mononuclear cells

References

• IARC. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. 1982; 29: 93–148
   Google Scholar
• Fan A M, Alexeeff G V. Public health goal for benzene in drinking water. Office of Environmental Health Hazard Assessment, California Environmental Protection Agency. Berkeley, CA 2001; 1–161
   Google Scholar
• Yaris F, Dikici M, Akbulut T, Yaris E, Sabuncu H. Story of benzene and leukemia: epidemiologic approach of Muzaffer Aksoy. J Occup Health 2004; 46: 244–247
   PubMed Web of Science ®Google Scholar
• Yin S N, Li G L, Tain F D, Fu Z I, Jin C, Chen Y J, et al. Leukaemia in benzene workers: a retrospective cohort study. Br J Ind Med 1987; 44: 124–128
   PubMedGoogle Scholar
• Sammett D, Lee E W, Kocsis J J, Snyder R. Partial hepatectomy reduces both metabolism and toxicity of benzene. J Toxicol Environ Health 1979; 5: 785–792
   PubMed Web of Science ®Google Scholar
• Valentine J L, Lee S S, Seaton M J, Asgharian B, Farris G, Corton J C, et al. Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol Appl Pharmacol 1996; 141: 205–213
   PubMed Web of Science ®Google Scholar
• Smith M T, Fanning E W. Report on the workshop entitled: ‘Modeling chemically induced leukemia—implications for benzene risk assessment’. Leuk Res 1997; 21: 361–374
   PubMed Web of Science ®Google Scholar
• Thomas D J, Sadler A, Subrahmanyam V V, Siegel D, Reasor M J, Wierda D, Ross D. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells. Mol Pharmacol 1990; 37: 255–262
   PubMed Web of Science ®Google Scholar
• Ross D, Siegel D, Gibson N W, Pacheco D, Thomas D J, Reasor M, Wierda D. Activation and deactivation of quinones catalyzed by DT-diaphorase. Evidence for bioreductive activation of diaziquone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma. Free Radic Res Commun 1990; 8: 373–381
   PubMed Web of Science ®Google Scholar
• Larson R A, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau M M, Smith M T. Prevalence of the inactivating 609C→T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 1999; 94: 803–807
   PubMed Web of Science ®Google Scholar
• Iskander K, Jaiswal A K. Quinone oxidoreductases in protection against myelogenous hyperplasia and benzene toxicity. Chem Biol Interact 2005; 153 – 154: 147–157
   PubMed Web of Science ®Google Scholar
• Levay G, Ross D, Bodell W J. Peroxidase activation of hydroquinone results in the formation of DNA adducts in HL-60 cells, mouse bone marrow macrophages and human bone marrow. Carcinogenesis 1993; 14: 2329–2334
   PubMed Web of Science ®Google Scholar
• Pathak D N, Levay G, Bodell W J. DNA adduct formation in the bone marrow of B6C3F1 mice treated with benzene. Carcinogenesis 1995; 16: 1803–1808
   PubMed Web of Science ®Google Scholar
• Bodell W J, Pathak D N, Levay G, Ye Q, Pongracz K. Investigation of the DNA adducts formed in B6C3F1 mice treated with benzene: implications for molecular dosimetry. Environ Health Perspect 1996; 104(Suppl 6)1189–1193
   PubMed Web of Science ®Google Scholar
• Joseph P, Klein-Szanto A J, Jaiswal A K. Hydroquinones cause specific mutations and lead to cellular transformation and in vivo tumorigenesis. Br J Cancer 1998; 78: 312–320
   PubMed Web of Science ®Google Scholar
• Nakayama A, Koyoshi S, Morisawa S, Yagi T. Comparison of the mutations induced by p-benzoquinone, a benzene metabolite, in human and mouse cells. Mutat Res 2000; 470: 147–153
   PubMed Web of Science ®Google Scholar
• Sakai A, Miyata N, Takahashi A. Initiating activity of quinones in the two-stage transformation of BALB/3T3 cells. Carcinogenesis 1995; 16: 477–481
   PubMed Web of Science ®Google Scholar
• Eastmond D A. Induction of micronuclei and aneuploidy by the quinone-forming agents benzene and o-phenylphenol. Toxicol Lett 1993; 67: 105–118
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J, Rowley J D. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994; 83: 2780–2786
   PubMed Web of Science ®Google Scholar
• Smith M T, Zhang L, Wang Y, Hayes R B, Li G, Wiemels J, et al. Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res 1998; 58: 2176–2181
   PubMed Web of Science ®Google Scholar
• Zhang L, Eastmond D A, Smith M T. The nature of chromosomal aberrations detected in humans exposed to benzene. Crit Rev Toxicol 2002; 32: 1–42
   PubMed Web of Science ®Google Scholar
• Whysner J, Reddy M V, Ross P M, Mohan M, Lax E A. Genotoxicity of benzene and its metabolites. Mutat Res 2004; 566: 99–130
   PubMed Web of Science ®Google Scholar
• Cavalieri E L, Li K M, Balu N, Saeed M, Devanesan P, Higginbotham S, et al. Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis 2002; 23: 1071–1077
   PubMed Web of Science ®Google Scholar
• Saeed M, Rogan E, Cavalieri E. Mechanism of tumor initiation by the human carcinogen diethylstilbestrol: the defining link to natural estrogen. Proc Am Assoc Cancer Res 2005; 46: 499
   Google Scholar
• Saeed M, Gunselman S J, Higginbotham S, Rogan E, Cavalieri E. Formation of the depurinating N3adenine and N7guanine adducts by reaction of DNA with hexestrol-3′,4′-quinone or enzyme-activated 3′-hydroxyhexestrol. Implications for a unifying mechanism of tumor initiation by natural and synthetic estrogens. Steroids 2005; 70: 37–45
   PubMed Web of Science ®Google Scholar
• Cavalieri E, Rogan E, Chakravarti D. The role of endogenous catechol quinones in the initiation of cancer and neurodegenerative diseases. Methods Enzymol 2004; 382: 293–319
   PubMed Web of Science ®Google Scholar
• Chakravarti D, Mailander P C, Li K M, Higginbotham S, Zhang H L, Gross M L, et al. Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene 2001; 20: 7945–7953
   PubMed Web of Science ®Google Scholar
• NIH. NIH guidelines for the laboratory use of chemical carcinogens. US Government Printing Office, Washington, DC 1981
   Google Scholar
• Saeed M, Zahid M, Rogan E, Cavalieri E. Synthesis of the catechols of natural and synthetic estrogens by using 2-iodoxybenzoic acid (IBX) as the oxidizing agent. Steroids 2005; 70: 173–178
   PubMed Web of Science ®Google Scholar
• Pezzella A, Lista L, Napolitano A, D'lschia M. An expedient one-pot entry to catecholestrogens and other catechol compounds via IBX-mediated phenolic oxygenation. Tetrahedron Lett 2005; 46: 3541–3544
   Web of Science ®Google Scholar
• Joshi S S, Lynch J C, Pavletic S Z, Tarantolo S R, Pirruccello S J, Kessinger A, Bishop M R. Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics. Blood 2001; 98: 1963–1970
   PubMed Web of Science ®Google Scholar
• Li K M, Todorovic R, Devanesan P, Higginbotham S, Kofeler H, Ramanathan R, et al. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 2004; 25: 289–297
   PubMed Web of Science ®Google Scholar
• Wiemels J, Smith M T. Enhancement of myeloid cell growth by benzene metabolites via the production of active oxygen species. Free Radic Res 1999; 30: 93–103
   PubMed Web of Science ®Google Scholar
• Ibuki Y, Goto R. Dysregulation of apoptosis by benzene metabolites and their relationships with carcinogenesis. Biochim Biophys Acta 2004; 1690: 11–21
   PubMed Web of Science ®Google Scholar
• Ruiz-Ramos R, Cebrian M E, Garrido E. Benzoquinone activates the ERK/MAPK signaling pathway via ROS production in HL-60 cells. Toxicology 2005; 209: 279–287
   PubMed Web of Science ®Google Scholar
• Hiraku Y, Kawanishi S. Oxidative DNA damage and apoptosis induced by benzene metabolites. Cancer Res 1996; 56: 5172–5178
   PubMed Web of Science ®Google Scholar
• Cavalieri E L, Rogan E G, Chakravarti D. Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism. Cell Mol Life Sci 2002; 59: 665–681
   PubMed Web of Science ®Google Scholar
• Nutter L M, Zhou B, Sierra E E, Wu Y Y, Rummel M M, Gutierrez P, Abul-Hajj Y. Cellular biochemical determinants modulating the metabolism of estrone 3,4-quinone. Chem Res Toxicol 1994; 7: 609–613
   PubMed Web of Science ®Google Scholar
• Iverson S L, Shen L, Anlar N, Bolton J L. Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes. Chem Res Toxicol 1996; 9: 492–499
   PubMed Web of Science ®Google Scholar
• Zahid M, Kohli E, Saeed M, Rogan E, Cavalieri E. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity. Chem Res Toxicol 2006; 19: 164–172
   PubMed Web of Science ®Google Scholar
• Tabakovic K, Gleason W B, Ojala W H, Abul-Hajj Y J. Oxidative transformation of 2-hydroxyestrone. Stability and reactivity of 2,3-estrone quinone and its relationship to estrogen carcinogenicity. Chem Res Toxicol 1996; 9: 860–865
   PubMed Web of Science ®Google Scholar
• Lin P H, Nakamura J, Yamaguchi S, Asakura S, Swenberg J A. Aldehydic DNA lesions induced by catechol estrogens in calf thymus DNA. Carcinogenesis 2003; 24: 1133–1141
   PubMed Web of Science ®Google Scholar
• Mobley J A, Bhat A S, Brueggemeier R W. Measurement of oxidative DNA damage by catechol estrogens and analogues in vitro. Chem Res Toxicol 1999; 12: 270–277
   PubMed Web of Science ®Google Scholar
• Cavalieri E. Minisymposium on endogenous carcinogens: the catechol estrogen pathway. An introduction. Polycyclic Aromatic Compd 1994; 6: 223–228
   Google Scholar
• Hiraku Y, Yamashita N, Nishiguchi M, Kawanishi S. Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation. Int J Cancer 2001; 92: 333–337
   PubMed Web of Science ®Google Scholar
• Zhao Z, Kosinska W, Khmelnitsky M, Cavalieri E L, Rogan E G, Chakravarti D, et al. Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB Rat2 embryonic cells, and the mutational spectrum of 4-hydroxyestradiol. Chem Res Toxicol 2006; 19: 475–479
   PubMed Web of Science ®Google Scholar
• Li J J, Li S A. Estrogen carcinogenesis in Syrian hamster tissue: role of metabolism. Fed Proc 1987; 46: 1858–1863
   PubMedGoogle Scholar
• Liehr J G, Fang W F, Sirbasku D A, Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 1986; 24: 353–356
   PubMedGoogle Scholar
• Newbold R R, Liehr J G. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 2000; 60: 235–237
   PubMed Web of Science ®Google Scholar
• Russo J, Hasan Lareef M, Balogh G, Guo S, Russo I H. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol 2003; 87: 1–25
   PubMed Web of Science ®Google Scholar
• Mailander P C, Khan G A, Meza J L, Higginbotham S, Chakravarti D. Induction of abundant A.T to G.C mutations by erroneous repair of estrogen-induced depurinated DNA in the mammary gland of ACI rats. J Steroid Biochem Mol Biol 2006; 101: 204–215
   PubMed Web of Science ®Google Scholar
• Fahlman M M, Boardley D, Flynn M G, Bouillon L E, Lambert C P, Braun W A. Effects of hormone replacement therapy on selected indices of immune function in postmenopausal women. Gynecol Obstet Invest 2000; 50: 189–193
   PubMed Web of Science ®Google Scholar
• Felix C A. Secondary leukemias induced by topoisomerase-targeted drugs. Biochim Biophys Acta 1998; 1400: 233–255
   PubMed Web of Science ®Google Scholar
• Lovett B D, Strumberg D, Blair I A, Pang S, Burden D A, Megonigal M D, et al. Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints. Biochemistry 2001; 40: 1159–1170
   PubMed Web of Science ®Google Scholar
• Zhuo X, Zheng N, Felix C A, Blair I A. Kinetics and regulation of cytochrome P450-mediated etoposide metabolism. Drug Metab Dispos 2004; 32: 993–1000
   PubMed Web of Science ®Google Scholar
• Kessinger A, Armitage J O, Smith D M, Landmark J D, Bierman P J, Weisenburger D D. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 1989; 74: 1260–1265
   PubMed Web of Science ®Google Scholar